AbbVie Balance Sheet
NYSE: ABBVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
AbbVie financial position
At the end of fiscal 2025, AbbVie reported total assets of $133.96 billion, down 0.9% from a year earlier against total liabilities of $137.19 billion. Shareholders' equity was negative at -$3.27 billion, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $5.23 billion in cash and equivalents against $67.50 billion of debt, a net debt position of $62.27 billion.
The current ratio (current assets divided by current liabilities) was 0.67, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
AbbVie balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.23B | 5.52B | 12.81B | 9.20B | 9.75B | 8.45B | 39.92B | 7.29B | 9.30B | 5.10B |
| Short-Term Investments | 28.00M | 31.00M | 2.00M | 28.00M | 84.00M | 30.00M | 0 | 772.00M | 486.00M | 1.32B |
| Receivables | 12.59B | 10.92B | 11.15B | 11.25B | 9.98B | 8.82B | 5.43B | 5.38B | 5.09B | 4.76B |
| Inventory | 4.95B | 4.18B | 4.10B | 3.58B | 3.13B | 3.31B | 1.81B | 1.60B | 1.60B | 1.44B |
| Total Current Assets | 29.06B | 25.58B | 33.00B | 28.46B | 27.93B | 24.17B | 49.52B | 16.95B | 21.22B | 16.19B |
| Property, Plant & Equipment | 5.63B | 5.13B | 4.99B | 4.93B | 5.11B | 5.25B | 2.96B | 2.88B | 2.80B | 2.60B |
| Goodwill | 35.64B | 34.96B | 32.29B | 32.16B | 32.38B | 33.12B | 15.60B | 15.66B | 15.79B | 15.42B |
| Intangible Assets | 52.64B | 60.07B | 55.61B | 67.44B | 75.95B | 82.88B | 18.65B | 21.23B | 27.56B | 28.90B |
| Long-Term Investments | 268.00M | 279.00M | 304.00M | 241.00M | 277.00M | 293.00M | 93.00M | 1.42B | 2.09B | 1.78B |
| Total Assets | 133.96B | 135.16B | 134.71B | 138.81B | 146.53B | 150.56B | 89.11B | 59.35B | 70.79B | 66.10B |
| Accounts Payable | 3.59B | 2.94B | 3.69B | 2.93B | 2.88B | 2.28B | 1.45B | 1.55B | 1.47B | 1.41B |
| Short-Term Debt | 8.55B | 6.80B | 7.19B | 4.14B | 12.49B | 8.50B | 3.75B | 5.31B | 6.42B | 402.00M |
| Total Current Liabilities | 43.29B | 38.75B | 37.84B | 29.54B | 35.19B | 28.66B | 15.59B | 17.24B | 16.64B | 9.78B |
| Long-Term Debt | 58.94B | 60.34B | 52.19B | 59.13B | 64.19B | 77.55B | 62.98B | 35.00B | 30.95B | 36.44B |
| Total Liabilities | 137.19B | 131.80B | 124.31B | 121.52B | 131.09B | 137.47B | 97.29B | 67.80B | 65.69B | 61.46B |
| Shareholders' Equity | -3.27B | 3.33B | 10.36B | 17.25B | 15.41B | 13.08B | -8.17B | -8.45B | 5.10B | 4.64B |
| Retained Earnings | -15.49B | -7.90B | -1.00B | 4.78B | 3.13B | 1.05B | 4.72B | 3.37B | 5.46B | 4.38B |
| Total Debt | 67.50B | 67.14B | 59.38B | 63.27B | 76.68B | 86.06B | 66.73B | 40.31B | 37.37B | 36.84B |
| Net Cash (Debt) | -62.24B | -61.59B | -46.57B | -54.04B | -66.85B | -77.58B | -26.80B | -32.25B | -27.58B | -30.42B |
This table shows 10 annual periods of AbbVie's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ABBV's reporting calendar. What is a balance sheet?